Medications

Cochrane group skeptical about latest Roche pledges

(HealthDay)—Following requests from Cochrane researchers, Roche has pledged to release full clinical study reports for Tamiflu, although there appear to be conditions attached, according to correspondence published in BMJ.

Medications

New online tool helps industry identify drug interactions

Drug interactions and drug side effects occur all-too-often in patients' lives. Now there's a new online resource to help guide pharmaceutical developers as they endeavor to improve testing for potentially harmful drug interactions ...

Medications

Tamiflu and Relenza: How effective are they?

Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza. This is according ...

Diseases, Conditions, Syndromes

Just how severe is this flu season?

(HealthDay)—If the headlines are any indication, this year's flu season is turning out to be a whopper.

Medications

Liquid tamiflu for kids in short supply

(HealthDay)—Manufacturing problems have created a shortage of the liquid form of Tamiflu, which is designed for young children who can't swallow capsules, U.S. health officials announced Wednesday.

Diseases, Conditions, Syndromes

CDC: Flu seems to level off except in the West

New government figures show that flu cases seem to be leveling off nationwide. Flu activity is declining in most regions although still rising in the West.

Medications

Roche sales up 5 percent amid rush for Tamiflu, cancer drugs

Swiss drug giant Roche said Thursday that heightened demand for its Tamiflu drug amid a severe flu season, as well as for its cancer medicines had sent its first-quarter sales up five percent, beating analyst expectations.

page 3 from 10